The Lancet Gastroenterology & Hepatology in conversation with

Colorectal cancer risk in patients with Crohn’s disease

March 12, 2020 The Lancet
The Lancet Gastroenterology & Hepatology in conversation with
Colorectal cancer risk in patients with Crohn’s disease
Show Notes

Ola Olén discusses the assesment of colorectal cancer risk in patients with Crohn's disease.

Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv